1. Home
  2. PDFS vs ARDX Comparison

PDFS vs ARDX Comparison

Compare PDFS & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PDF Solutions Inc.

PDFS

PDF Solutions Inc.

HOLD

Current Price

$34.18

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$5.30

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDFS
ARDX
Founded
1992
2007
Country
United States
United States
Employees
N/A
489
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2000
2014

Fundamental Metrics

Financial Performance
Metric
PDFS
ARDX
Price
$34.18
$5.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
$33.67
$15.14
AVG Volume (30 Days)
246.1K
3.1M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,607,000.00
Revenue This Year
$22.13
$38.22
Revenue Next Year
$18.92
$33.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.91
$3.50
52 Week High
$36.99
$8.40

Technical Indicators

Market Signals
Indicator
PDFS
ARDX
Relative Strength Index (RSI) 55.79 30.93
Support Level $30.72 $4.81
Resistance Level $34.97 $5.34
Average True Range (ATR) 1.54 0.26
MACD 0.06 -0.06
Stochastic Oscillator 79.33 2.40

Price Performance

Historical Comparison
PDFS
ARDX

About PDFS PDF Solutions Inc.

PDF Solutions Inc provides products and services designed to empower organizations across the semiconductor and electronics ecosystem to connect, collect, manage, and analyze data about design, equipment, manufacturing, and test to improve the yield and quality of their products and operational efficiency. The Company's products, services, and solutions include proprietary software, physical intellectual property (IP) for integrated circuit (IC) designs, electrical measurement hardware tools, methodologies, and professional services.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: